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ABSTRACT Incubation of extracts of +29-infected Bacillus
subtilis with [a-32pl]dATP produced a labeled protein having the
electrophoretic mobility of p3, the 5'-terminal protein of 4.29
DNA. The reaction product was resistant to treatment with mi-
crococcal nuclease, phosphatase, and RNases A and T1 and sen-
sitive to proteinase K. Incubation of the 32P-labeled protein with
piperidine under conditions in which the 429 DNA-protein p3
linkage is hydrolyzed released 5'-dAMP. The, reaction with [a-
32P]dATP was strongly inhibited by anti-p3 serum and required
the presence of 429 DNA-protein p3 complex; no reaction took
place with proteinase K-treated 429 DNA. These results, together
with those of acid hydrolysis and partial proteolysis, indicated that
a covalent complex between protein p3 and 5'-dAMP is formed
in vitro. The initiation complex (protein p3-dAMP) formed in the
presence of 0.5 FAM [a-32P]dATP can be elongated by addition of
40 ,AM dNTPs. Treatment with piperidine of the product elon-
gated in the presence of 2',3'-dideoxycytidine 5'-triphosphate re-
leased the expected oligonucleotides, 9 and 12 bases long, taking
into account the sequence at the left and right DNA ends,
respectively.
DNA polymerases cannot start new polynucleotide chains be-
cause they need a free 3'-OH group for polymerization. There-
fore, a key feature in replication is how aDNA chain is initiated.
The RNA-priming mechanism will not solve the problem of ini-
tiation' in the case of a linear DNA since filling the gap at the
5' ends after RNA excision cannot take place as no 3'-OH end
is present. Therefore, a mechanism different from RNA priming
must be found to initiate DNA synthesis at the ends of a linear
DNA molecule. The existence of a specific protein covalently
linked to the 5' ends of viral DNA molecules, such as those of
phage 429 (1-4) and adenovirus (5, 6), has been implicated in
solving this problem.
The Bacilus subtilis phage 429 genome is a linear double-
stranded DNA containing about 18,000 base pairs (7), with a
protein, p3, covalently linked to the 5' ends through a phos-
phoester bond between the OH group of a serine residue and
5'-dAMP (8). An inverted terminal repetition six nucleotides
long is present at the ends of )29 DNA (9, 10). In vivo shift-up
experiments using temperature-sensitive mutants in cistron 3
have shown that protein p3 is involved in the initiation ofDNA
replication (11). The replication of4)29 DNA starts at both DNA
ends, not simultaneously, and occurs by a mechanism of strand
displacement (12-14).
A model for the initiation of adenovirus (5) and 429 DNA
replication (11-13) has been proposed in which a free molecule
of the terminal protein, after recognizing the parental protein
at the ends of the DNA, the inverted terminal repetition, or
both, reacts with the 5'-terminal dNTP and forms a protein-
dNMP covalent linkage, thus providing the 3'-OH group
needed by the DNA polymerase. Consistent with this model
is the presence of terminal protein linked to the ends of the
parental and daughter DNA strands of replicating. molecules of
adenovirus (15-18) and phage 429 (14). Moreover, a covalent
complex between the precursor ofthe adenovirus terminal pro-
tein and 5'-dCMP, the terminal nucleotide at both DNA ends,
has been shown recently to be formed in vitro (refs. 19-22; P.
C. Van der Vliet, personal communication).
In this paper, we show that extracts from +29-infected B.
subtilis incubated with dATP catalyze the formation of a cova-
lent complex between protein p3 and 5'-dAMP, the 5'-terminal
nucleotide at both DNA ends (8-10). Formation of the protein
p3-dAMP covalent linkage is specifically inhibited by anti-p3
serum and requires the presence of the 429 DNA-protein p3
complex and ATP; no reaction takes place with proteinase K-
treated 429 DNA. Moreover, the complex between protein p3
and dAMP can be elongated to a protein p3-oligonucleotide
complex 9 and 12 bases long when 2',3'-dideoxycytidine 5'-tri-
phosphate (ddCTP) is used, as expected from the sequence at
the DNA ends (9, 10). These results support the model in which
the terminal protein functions as a primer for the initiation of
4)29 DNA replication.
MATERIALS AND METHODS
Materials. [a-32P]dATP (410 Ci/mmol; 1 Ci = 3.7 X 1010
becquerels), [a-32P]dTTP(410 Ci/mmol), [a-3'P]ATP (410 Ci/
mmol), and cordycepin [a-32P]5'-triphosphate (3,000 Ci/mmol)
were from Amersham. 2',3'-Dideoxyguanosine 5'-triphosphate
(ddGTP) and ddCTP were from P-L Biochemicals. Micrococcal
nuclease and RNases A and T1 were from Worthington; alkaline
phosphatase from calf intestine was from Boehringer Mann-
heim; and fungal proteinase K, chromatographically purified,
was from Merck. 429 DNA-protein p3 complex was obtained
by treatment of phage with 4 M guanidinium chloride for 1 hr
at 0WC. The mixture was layered on top ofa linear CsCl gradient
as described (1), except that centrifugation was for 5.5 hr at
58,000 rpm in an SW 65 rotor. 429 DNA was obtained by phe-
nol extraction from proteinase K-treated phage particles (23).
'S-Labeled protein p3-DNA complex was prepared by J. M.
Izaro and rabbit anti-p3 serum was prepared by I. Prieto.
Growth ofCells andPreparation of Extracts. B. subtilis F25-
1 or HA101(59)F, lackingDNA polymerase I activity (24), kindly
provided by N. Cozzarelli, was grown at 370C in LB broth up
to a cell density of 1 x 108 bacteria per ml and infected with
wild-type phage 029 at a multiplicity of 10. At 45 min postin-
fection, the cells were harvested and washed once with 50 mM
Abbreviations: ddCTP, 2',3'-dideoxycytidine 5'-triphosphate; ddGTP,
2',3'-dideoxyguanosine 5'-triphosphate.
5522
The publication costs ofthis article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertise-
ment" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
Proc. Natl. Acad. Sci. USA 79 (1982) 5523
Tris HCl, pH 7.5/10% sucrose and then stored at
-800Cx Con-trol uninfected cells were processed as the infected cells.
Frozen cells were thawed, suspended in 1/200th the original
volume of 50 mM TrisHCI, pH 7.5/125 mM NaCl containing
lysozyme at 500,ug/ml and incubated for 1 hr at00C to lyse the
cells. Bacterial debris and DNA, both membrane-bound and
of high molecular weight, were removed by centrifugation for
30 min at 40,000x g. The pellet was processed as described
below. The supernatant (fraction I), containing 7-10 mg of pro-
tein/ml, was treated with 0.47 g of ammonium sulfate per ml.
The precipitate was dissolved in a small volume of 50 mM
Tris'HCI, pH 7.5/0.1 mM dithiothreitol/20% (vol/vol) glycerol
(buffer A) to a protein concentration of 15-25 mg/ml, and the
solution was dialyzed against the same buffer (fraction II). Frac-
tions I and II contained endogenous DNA.
The pellet from 2 ml of lysate obtained as indicated above
was suspended in 1 ml of 50 mM Tris HCl (pH 7.5). The bulk
of the DNA was removed by phage partition with polyethylene
glycol 8000-dextran 500 in 4 M NaCl (25). After a short dialysis
to eliminate the salt, polyethylene glycol was removed by ad-
dition of ammonium sulfate (0.2 g/ml) and the protein was pre-
cipitated from the aqueous phase by addition ofammonium sul-
fate (0.26 g/ml). The precipitate was dissolved in a small volume
of buffer A to a concentration of protein of 7-10 mg/ml, and
this solution was dialyzed against the same buffer (fraction III).
This fraction also contained endogenous DNA.
To remove nucleic acids, fraction I (=20 mg of protein) was
adjusted to 0.3 M KCI and applied to a DEAE-cellulosecolumn
(6 X 1.7 cm) equilibrated with 50 mM Tris HCl, pH 7.5/0.3
M KCI. The flow-through material was concentrated by addi-
tion of ammonium sulfate (0.47 g/ml), the precipitate was dis-
solved in a small volume of buffer A to a concentration ofprotein
of 15-20 mg/ml, and this solution was dialyzed against the same
buffer (fraction IV). All fractions were stored at
-80°C for sev-
eral months with no detectable loss of activity when assayed for
formation of the protein p3-dAMP complex in the standard ini-
tiation reaction.
Assay for Formation of Protein-dAMP Complex (Initiation
Reaction). The standard incubation mixture for the initiation
reaction was (final volume, 0.1 ml) 50 mMTrisHHCl, pH 7.5/
5 mM MgCl2/3 mM ATP/0.2,u M [a-32p]dATp (10Ci)/10,uM ddGTP containing =200,ug of protein from fraction I,II,or IV or 35,ug of protein from fraction III. When fraction IV
was used,0.77,g of )29 DNA-protein p3 complex or proteinase
K-treated 429 DNA was added as indicated. After incubation
for 20min at30° C or37° C as indicated, 10 mM EDTA/0. 1%
NaDodSO4 was added, and the sample was heated for 10minat68°C. Free [a-32p]dATP was removed by gel filtration on a
Sephadex G-5O column equilibrated with 50 mMTrisHHCI (pH8.8). Radioactive material eluting in the void volume was
treated, unless otherwise indicated, with micrococcal nuclease
(250 units/ml) in the presence of 10 mM CaCl2 for 30min at370C, precipitated with 10% trichloroacetic acid, and subjected
to electrophoresis in polyacrylamide slab gels containing 10%
acrylamide/0. 1% NaDodSO4 as described (26). The gels were
dried and autoradiography was carried out with Ilford fast tung-
state intensifying screens at -800C.35S-Labeled 429 structural
proteins were used as molecular weight markers (27).
RESULTS
Formation of Protein p3-dAMP Covalent Linkage. When
extracts of 029-infected B. subtilis (fraction I) containing en-
dogenous 429 DNA (28) were incubated with [a-32P]dATP as
described above and the product was analyzed by NaDodSO4/
polyacrylamide gel electrophoresis, a 32P-labeled band running
in the position of protein p3 was found (Fig. 1A, lanes a and c).
A
a b c d
--84
70
_-52
--48
->x 275
I ...
B c
a b c d
| --84
|
~~~70
*
--52
-48
--40
X -275
w-_40 P3V
lime
....
a b c
-84
-70
- 52
-48
*-40
27.5
\p3
FIG. 1. Labeling of protein p3 by incubation of extracts from 429-
infected cells with [a-52P]dATP. (A) Fifty-microliter samples of frac-
tion I from infected (lane a) or uninfected (lane b) cells were incubated
for 20 min at 370C with [a-32P]dATP in the presence of ddGTP, pro-
cessed, and subjected to NaDodSO4/polyacrylamide gel electrophore-
sis. Lanec:3"S-labeled protein p3 prepared by treatment of35S-labeled
protein p3-DNA complex with micrococcal nuclease to degrade the
DNA up to the last nucleotide (8). (B) Ten-microliter samples of frac-
tion II from infected (lanes a and b) or uninfected (lane c) cells were
incubated for 20min at 370C and processed as described in Materials
and Methods except that the sample in lane a was not treated with
micrococcal nuclease. (C) Ten-microliter samples of fraction III from
infected cells were incubated for 20min at 300C and processed without
(lane a) or with (lane b) micrococcal nuclease treatment. Mr markers:
A, lane d; B, lane d; C, lane c; values given are x10-3.
No32P-labeled band having this electrophoretic mobility was
produced when extracts from uninfected cells were used (Fig.
lA, lane b). To increase the efficiency of labeling, the extracts
were treated with ammonium sulfate to eliminate endogenous
nucleotides (fraction II). After incubation with [a-32p]dATP,
analysis by NaDodSO4/polyacrylamide gel electrophoresis
showed the presence of an abundant32pPlabeled band running
in the position of protein p3 (Fig. 1B). The position of the band
was the same whether or not the sample was treated with mi-
crococcal nuclease before electrophoresis (Fig. LB, lanes a and
b), although the amount of 32P-labeled material running down
the gel was drastically reduced by this treatment. The amount
of radioactivity (32P) remaining in the protein p3 band after nu-
clease treatment was 3.5ffol. When fraction II from extracts
of uninfected cells was incubated with [a-32p]dATp, no radio-
active band in the position of protein p3 was found (Fig. 1B, lane
c). Fig. LC shows the formation of the 32P-labeled protein p3
band when fraction III was used without (lane a) or with (lane
b) micrococcal nuclease treatment. The amount of 32P radio-
activity in this band was 3.3fmol. The amount of 32P-labeled
material running down the gel in the sample untreated with
micrococcal nuclease is much less with fraction III than with
fraction II.
The 32P-labeled protein p3 band was drastically decreased
when ATP was omitted (Fig. 2A, lanes a and b) and disappeared
completely in the absence Of MgCl2 (lane c) or in the presence
of 0.35 MKCI (lane d), a concentration that does not inhibit )29
DNA elongation in the in vitro system (28). When [a-32p]dTTP,
[a_32p]ATp, or [a-32p] cordycepin 5'-triphosphate was substi-
tuted for [a-32p]dATP, no 32P-labeled band at the position of
protein p3 was detected (Fig. 2B, lanes a-c). The labeled bands
present when the incubation was carried out in the absence of
ATP (Fig. 2A, lane b) or when [a-32p]ATP was used instead of
[a-32p]dATp (Fig. 2B, lane b) are sensitive to proteinase K treat-
Biochemistry: Pefialva and Salas
5524 Biochemistry: Pefialva and Salas
A B
a b c d e a b c d
-84
--70
-- 52
-48
---40
--275
\ P3
a
a _-84
-70
-
-52
_0 - -48
-
_-, 40
_ 27 5
P3
-
_ _
FIG. 2. Requirements for formation of the 32P-labeled protein p3
band. (A) Ten-microliter samples of fractionIl from infected cells were
incubated for 20 min at 37°C with [a-32P]dATP, ATP as indicated, and
ddGTP, processed, and subjected to NaDodSO4/polyacrylamide gel
electrophoresis. Lanes: a, control; b, without ATP; c, without MgCl2;
d, with 0.35 M KCl. (B) As in A except that [a-32P]dATP was absent.
Lanes: a, with [a-32P]dTTP (10 ,Ci); b, with [a-32P]ATP (10 ,uXi; 0.24
XM); c, with cordycepin 5'-[a-32Pltriphosphate (10 ,ACi). Mr markers:
A, lane e; B, lane d; values given are x10-3.
ment, and they were present when extracts from uninfected
cells were used.
The 32P-labeled protein p3 band remained after treatment
with phosphatase or RNase A and RNase Ti, although most of
the other 32P-labeled bands disappeared after phosphatase
treatment (Fig. 3, lanes a-c). Most of the bands present when
extracts from uninfected cells were used also disappeared after
phosphatase treatment (lanes fand g). By treatment with either
proteinase K or piperidine (under conditions in which the pro-
tein p3-DNA linkage is hydrolyzed; unpublished results), the
32P-labeled protein p3 band completely disappeared (lanes d
and e). Lane h shows the electrophoretic mobility of 'S-labeled
protein p3 released from the DNA-p3 complex by treatment
with piperidine.
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FIG. 3. Sensitivity of the 32P-labeled protein p3 band to various
treatments. Ten-microliter samples of fraction IH from infected (lanes
a-e) or uninfected (lanes f and g) cells were incubated for 20 min at370C with [a-32P~dATP and ddGTP, treated with micrococcal nuclease
as indicated.below, and subjected to NaDodSO4/polyacrylamide gel
electrophoresis. Lanes: a, control; b, with phosphatase (1 unit/ml) for
30 min at 370C; c, with RNase A (5 pg/ml) and RNase T1 (4 units/
ml) for 30 min at 37°C; d, with proteinase K (200 pg/nil) in the pres-
ence of 0.1% NaDodSO4 for 3 hr at 370C; e, with 0.5 M piperidine for
2 hr at 370C; f, uninfected control; g, uninfected, treated with phos-
phatase as for lane b; h, 35S-labeled protein p3 prepared from 35S-la-
beled protein p3-DNA complex by treatment with micrococcal nu-
clease and then with 0.5 M piperidine for 2 hr at 370C; i, Mr markers
(values are X 10-3).
Characterization of the Protein Labeled with [a-32P]dATP
as p3. To determine whether the protein labeled in vitro with[a- 2P]dATP was p3, the effect of anti-p3 serum on the reaction
was tested. Fraction III from infected cells was incubated with
serum against protein p3 before addition of the remaining com-
ponents of the in vitro initiation reaction. The labeling of the
protein p3 band was strongly inhibited (-65%; Fig. 4, lanes d
and e) compared with experiments in which no serum (lane a)
or nonimmune serum (lanes b and c) were added. Additional
indications that the protein labeled in vitro was p3 were that
(i) acid hydrolysis of the 32P-labeled protein yielded phospho-
serine under conditions in which this product was formed from
the 429 DNA-protein p3 complex (8) and (ii) partial hydrolysis
with V8 protease (29) of the 32P-labeled protein and %S-labeled
protein p3 produced a common peptide having the same elec-
trophoretic mobility in NaDodSO4/polyacrylamide gels (data
not shown).
Characterization of the Nucleotide Moiety Covalently
Linked to Protein p3. Since the sequence at both 5' ends of429
DNA is A-A-A-G-T-A (9, 10), the reaction of protein p3 with
[a-32P]dATP in the presence ofddGTP would stop at the fourth
nucleotide if elongation takes place in vitro or at the first aden-
osine if no elongation occurs. It is known that, after digestion
of the protein p3-DNA complex with micrococcal nuclease,
pdAp remains attached to the protein (8). The 32P-labeled pro-
tein p3 formed in the standard incubation of fraction III with
[a-32P]dATP and ddGTP, either with. or without micrococcal
nuclease treatment, was eluted from a polyacrylamide gel. In
both cases, treatment with 0.5 M piperidine for 2 hr at 370C,
conditions that hydrolyze the protein p3-DNA linkagej re-
leased a radioactive product that comigrated with 5'-dAMP on
TLC on polyethyleneimine cellulose (Fig. 5, lanes b-d). No
radioactivity at the position of 5'-dAMP appeared when the
sample was not treated with piperidine (lane a). The fact that
the sample thathad not been treated with micrococcal nuclease
released 5'-dAMP as the major product (lane b) indicates that,
in the presence of 0.2 ,uAM dATP, most ofthe protein p3-dAMP
complex is not elongated further. This conclusion is supported
by the fact that, in the sample that had been treated with mi-
crococcal nuclease, only a small amount of the radioactivity re-
mained close to the origin, presumably as pdAp, since it ran in
the position of ADP and treatment with phosphatase released
its radioactivity at the Pi position (lane d). The radioactivity that
remains at the origin after piperidine treatment in the sample
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FIG. 4. Inhibition by anti-p3 serum of formation of the 32P-labeled
protein p3 band. Five-microliter samples of fraction HI from infected
cells were incubated for 10 min (lanes b and d) or 30 min (lanes c and
e) with 5 ,ul of nonimmune serum (lanes b and c) or anti-p3 serum
(lanes d and e) and then for 20 min at 3000 with [a-32P]dATP and
ddGTP, processed, and subjected to NaDodSO4/polyacrylamide gel
electrophoresis. Lane f, Mr markers (values are x 10-3).
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FIG. 5. Characterization of the nucleotide moiety linked to the
32P-labeled protein p3 band. The 32P-labeled protein p3 from untreated
samples (lanes a and b) or samples treated (lanes c and d) with micro-
coccal nuclease was eluted from the gel by overnight incubation with
50 mM Tris HCl, pH 7.5/0.1% NaDodSO4. The protein was precipitated
with acetone and suspended in water. A sample from each was applied
to a polyethyleneimine-cellulose plate before (lane a) or after (lanes b-
d) incubation with 0.5M piperidine for 2 hr at 37TC followedby removal
of the piperidine. The sample in lane d was treated with phosphatase
(6 units/ml) for 30 min at 37TC before treatment with piperidine. In
all cases, 5'-dAMP was added as an internal marker. 5'-ADP and Pi
were also run as markers. The chromatogram was developed first in
0.5% formic acid and then in 0.15 M lithium formate (pH 3.0) in the
same dimension.
not treated with the nuclease (lane b) is probably due to DNA
contamination in the region ofthe gel corresponding to the pro-
tein p3 band (see Fig. 1C).
Elongation of the Protein p3-dAMP Complex. To test
whether or not the protein p3-dAMP complex formed in vitro
can serve as a primer for elongation, a pulse-chase experiment
was carried out. Fraction III from infected cells was incubated
with 0.5 ,&M [a-32P]dATPfor5 min (pulse). Then, 40 puM dATP/
40 puM dGTP/40 ,M dTTP/40 pM dCTP was added and in-
cubation was continued up to 20 min (chase). The samples were
subjected to NaDodSO4/polyacrylamide gel electrophoresis
and the 32P radioactivity in the protein p3 band was quantitated
by densitometry. About 40% of the 32p radioactivity in the pro-
tein p3 band at the pulse (Fig. 6A, lane a) was chased into high
molecular weight material (lane b). Since the nucleotide se-
quence at the left and right 429 DNA 5' ends is A-A-A-G-T-A-
A-G-C . . . and A-A-A-G-T-A-G-G-G-T-A-C . . ., respec-
tively (9, 10), 100 pM ddCTP (instead of dCTP) was added to
a sample during the chase to stop the elongation at nucleotides
9 and 12. Under these conditions, about 40% ofthe radioactivity
appeared in a new band having an electrophoretic mobility less
than that of the protein p3-dAMP band, corresponding to a
molecular weight of 31,000 (Fig. 6A, lane c). When the Mr
31,000 band was eluted from the gel, hydrolyzed with piperi-
dine, and analyzed in a denaturing polyacrylamide gel, bands
corresponding to oligonucleotides 9 and 12 bases longwere seen
(Fig. 6B, lane a). This is the expected result for products elon-
gated in the presence ofddCTP. In addition, bands running in
the positions of the di- and pentanucleotide were present. The
band moving at the dinucleotide position was shown to be 5'-
dAMP, probably due to contamination with the material from
the main band. The pentanucleotide band could represent a
premature stop in elongation. No bands at any of the above
positions appeared when the piperidine treatment was omitted
(lane b).
In an experiment in which the dATP concentration was main-
tained at 0.5 ,M during the entire incubation period in the
presence of 40 ,M dGTP/40 ,M dTTP/100 AM ddCTP, the
amount of the Mr 31,000 band was much smaller than when 40
,M dATP was added after 5 min. When the dATP concentration
was maintained at 40 ,M during the entire incubation period,
about 2/3 of the radioactivity was present in the Mr 31,000 band
FIG. 6. Elongation of the protein p3-dAMP complex. (A) Thirty-
microliter samples of fraction III from infected cells were incubated in
a volume of 0.3 ml in the presence of 0.5 uM [a-32P]dATP (200 Ci/
mmol). After 5 min at 3000, a 0.1-ml sample was removed and the re-
action was stopped (lane a); 40 pM dATP/40 1iM dGTP/40 pM dTTP/
40 pM dCTP (lane b) or 40 pM dATP/40 uM dGTP/40 pM dTTP/100
,uM ddCTP (lane c) was added to samples of 0.1 ml and incubation was
continued for an additional 15 min. The samples were processed as
described in Materials and Methods except micrococcal nuclease treat-
ment was not carried out and electrophoresis was in NaDodSO4/20%
acrylamide slab gels. Lane d, Mr markers (values given are x 10-3).
(B) The 32P-labeled band with an apparent Mr of 31,000 was eluted
from the gel by overnight incubation with 50 mM Tris HCl, pH 7.5/
0.1% NaDodSO4, precipitated with acetone and suspended in water.
Lanes: a, half of the sample was treated with 0.5 M piperidine for 2
hr at 370C and, after removal of the piperidine, subjected to electro-
phoresis in a 20% polyacrylamide denaturing gel as described (10); b,
the other half was not treated with piperidine but was subjected to
electrophoresis as a control. The reaction products from a chemical
sequence analysis of DNA fragments labeled with T4 polynucleotide
kinase were run in parallel lanes as markers (gift from C. Escarmis).
(results not shown). These findings suggest that a high concen-
tration of dATP is required to elongate the initiation complex.
Template Requirement for Formation of the Protein p3-
dAMP Covalent Linkage. The endogenous 429 DNA was re-
moved from the extracts by DEAE-cellulose chromatography
(fraction IV), and this fraction was used as a protein source for
the reaction with [a-32P]dATP. Fig. 7A (lane c) shows that a 32p_
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Fno. 7. Templaterequirementfor formation of the protein p3-dAMP
complex. Ten-microliter samples of fraction IV from infected (lanes
a-c) or uninfected (lanes d and e) extracts were incubated for 20 min
at 3000 with [a-12P~dATP and ddGTP and no other additions (lane a)
or with 0.7 pg of proteinase K-treated 4029 DNA (lanes band d) or 0.7
pigof 4029 DNA-protein p3 complex (lanes c ande), processed, and sub-
jected to NaDodSO4-polyacrylamide gel electrophoresis. Lane f: Mr
markers (values given are 10-3).
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labeled band in the position of protein p3 appeared when 429
DNA-protein p3 complex was used as template. However, this
band did not appear when DNA was not added (lane a) or when
proteinase K-treated 429 DNA was added (lane b). Addition of
429-protein p3 complex or of proteinase K-treated 429 DNA
to fraction IV from uninfected cells did not give rise to a 32p_
labeled band at the position of protein p3 after incubation with
[a-32P]dATP (lanes d and e).
DISCUSSION
Extracts of+29-infected cells catalyzed the formation of a cova-
lent complex between a protein that has been characterized as
p3 and 5'-dAMP. In the presence of 0.2 puM [a-32P]dATP, a
very small amount of elongation occurred in vitro. However,
when 40 ,AM dATP/dGTP/dTTP/dCTP was added after a
pulse, about 40% ofthe p3-dAMP complex was chased into high
molecular weight material. Moreover, when 100 p.M ddCTP
was added instead of dCTP, to stop the elongation reaction at
nucleotides 9 and 12, according to the sequence at the left and
right DNA ends, respectively, a labeled Mr 31,000 band that
released oligonucleotides 9 and 12 bases long after piperidine
treatment was formed. The results suggest that the elongation
reaction requires a high nucleotide concentration since, when
a low dATP concentration (0.2-0.5 p.M) was maintained during
the incubation, a very small amount of elongated product was
obtained, consistent with the finding of protein p3-dAMP as
the major product. The fact that a complete chase ofthe protein
p3-dAMP complex was not obtained under those conditions
suggests that, for efficient elongation, this reaction must be
coupled to initiation. In support of this idea is the fact that,
when 40 ,uM dATP was used during the entire incubation pe-
riod, about 2/3 of the product was in an elongated form.
When endogenous DNA was eliminated from extracts of429-
infected cells, formation of the initiation complex was depen-
dent on the addition of protein p3-DNA complex as template.
No reaction took place with proteinase K-treated 429 DNA. A
similar result has been obtained with the adenovirus system
(19-22). However, it has been reported recently that, when the
residual peptides remaining after Pronase treatment ofadenovi-
rus DNA were eliminated by piperidine treatment, protein-free
DNA restriction fragments supported the initiation reaction
when a partially purified protein fraction was used but not with
crude extracts (22). The initiation reaction also occurred with
denatured Pronase-treated adenovirus DNA when the purified
protein fraction (22) or linearized plasmids containing the origin
of replication at the end were used as templates (ref. 22; P. C.
Van der Vliet, personal communication). We have used piper-
idine-treated Hpa II restriction fragments prepared from pro-
teinase K-digested 029 DNA-p3 complex, as well as denatured
029 DNA, as templates for the initiation reaction using the
DNA-free fraction as a protein source. Under those conditions,
no initiation complex was formed. As a control, Hpa II-treated
protein p3-DNA complex gave rise to protein p3-dAMP com-
plex (unpublished results). It is possible that, as in the adeno-
virus system, a purer protein fraction is required for initiation
when protein-free DNA is used as template. An alternative
possibility is that the 429 DNA initiation reaction has an ab-
solute requirement for the parental protein since the inverted
terminal repetition is only 6 nucleotides long (9, 10) in contrast
to the adenovirus DNA one of about 100 nucleotides (30-34).
An important question that remains is whether protein p3
itself or some other enzymatic activity, bacterial or phage-en-
coded, catalyzes the formation of the protein-dAMP complex.
The precursor ofthe terminal protein from adenovirus-infected
cells has been purified and shown to copurify with a DNA poly-
merase activity (35). Whether this DNA polymerase activity is
required for the initiation reaction remains to be determined.
In the case of 429 DNA initiation of replication in vitro, puri-
fication of protein p3 and the use of phage mutants blocked in
replication may help to answer this question.
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